| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |